{"entity":{"id":"de87f856-72ba-50af-b71c-88e7df9b47d9","name":"GlaxoSmithKline (Malta) Limited","type":"Company","kind":"company","jurisdiction":"MT","identifier":"icij:icijol-55031947","risk":"HIGH","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[{"role":"shareholder of","share":null,"party":{"id":"0fb0b07a-3ee2-508f-9d22-3583638921b9","name":"WELLCOME LTD","type":"Organization","kind":"company"}},{"role":"director of","share":null,"party":{"id":"d6bf50e2-3c16-551c-9f4f-f874197fd7ba","name":"MONICA ABDILLA","type":"Organization","kind":"company"}},{"role":"legal representative of","share":null,"party":{"id":"d6bf50e2-3c16-551c-9f4f-f874197fd7ba","name":"MONICA ABDILLA","type":"Organization","kind":"company"}},{"role":"director of","share":null,"party":{"id":"1faff030-7015-5fcf-8139-7dc9fdd553ad","name":"MARIO SCIBERRAS","type":"Organization","kind":"company"}},{"role":"legal representative of","share":null,"party":{"id":"1faff030-7015-5fcf-8139-7dc9fdd553ad","name":"MARIO SCIBERRAS","type":"Organization","kind":"company"}},{"role":"secretary of","share":null,"party":{"id":"50995f4d-807c-56a9-bd92-f7927480eea2","name":"PETER FENECH","type":"Organization","kind":"company"}},{"role":"director of","share":null,"party":{"id":"e2759858-0c2a-5671-8e8e-8202ef8aeed4","name":"DANIEL GIJBELS","type":"Organization","kind":"company"}},{"role":"legal representative of","share":null,"party":{"id":"e2759858-0c2a-5671-8e8e-8202ef8aeed4","name":"DANIEL GIJBELS","type":"Organization","kind":"company"}},{"role":"shareholder of","share":null,"party":{"id":"e2759858-0c2a-5671-8e8e-8202ef8aeed4","name":"DANIEL GIJBELS","type":"Organization","kind":"company"}}],"holdings":[],"ubo_chain":[{"depth":1,"from":"0fb0b07a-3ee2-508f-9d22-3583638921b9","fromName":"WELLCOME LTD","to":"de87f856-72ba-50af-b71c-88e7df9b47d9","toName":"GlaxoSmithKline (Malta) Limited","role":"shareholder of","share":null},{"depth":1,"from":"d6bf50e2-3c16-551c-9f4f-f874197fd7ba","fromName":"MONICA ABDILLA","to":"de87f856-72ba-50af-b71c-88e7df9b47d9","toName":"GlaxoSmithKline (Malta) Limited","role":"director of","share":null},{"depth":1,"from":"d6bf50e2-3c16-551c-9f4f-f874197fd7ba","fromName":"MONICA ABDILLA","to":"de87f856-72ba-50af-b71c-88e7df9b47d9","toName":"GlaxoSmithKline (Malta) Limited","role":"legal representative of","share":null},{"depth":1,"from":"1faff030-7015-5fcf-8139-7dc9fdd553ad","fromName":"MARIO SCIBERRAS","to":"de87f856-72ba-50af-b71c-88e7df9b47d9","toName":"GlaxoSmithKline (Malta) Limited","role":"director of","share":null},{"depth":1,"from":"1faff030-7015-5fcf-8139-7dc9fdd553ad","fromName":"MARIO SCIBERRAS","to":"de87f856-72ba-50af-b71c-88e7df9b47d9","toName":"GlaxoSmithKline (Malta) Limited","role":"legal representative of","share":null},{"depth":1,"from":"50995f4d-807c-56a9-bd92-f7927480eea2","fromName":"PETER FENECH","to":"de87f856-72ba-50af-b71c-88e7df9b47d9","toName":"GlaxoSmithKline (Malta) Limited","role":"secretary of","share":null},{"depth":1,"from":"e2759858-0c2a-5671-8e8e-8202ef8aeed4","fromName":"DANIEL GIJBELS","to":"de87f856-72ba-50af-b71c-88e7df9b47d9","toName":"GlaxoSmithKline (Malta) Limited","role":"director of","share":null},{"depth":1,"from":"e2759858-0c2a-5671-8e8e-8202ef8aeed4","fromName":"DANIEL GIJBELS","to":"de87f856-72ba-50af-b71c-88e7df9b47d9","toName":"GlaxoSmithKline (Malta) Limited","role":"legal representative of","share":null},{"depth":1,"from":"e2759858-0c2a-5671-8e8e-8202ef8aeed4","fromName":"DANIEL GIJBELS","to":"de87f856-72ba-50af-b71c-88e7df9b47d9","toName":"GlaxoSmithKline (Malta) Limited","role":"shareholder of","share":null}]},"risk":{"level":"HIGH","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"icij_offshoreleaks","source_url":"https://offshoreleaks.icij.org/nodes/55031947"}],"source":"corpus"}